The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation.

Front Immunol · 2024 · PMC11043518 · PMID 38665912

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

BM chimerism of early relapse patients showed a decreasing trend at 3 months after allo-HSCT, while the PB chimerism decreasing tendency was preserved at 6 months after allo-HSCT ( Figures 4B, C ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.